Dr. Robert D. Cullen, M.D.
ENT (Otolaryngology) (Otology & Neurotology Physician)
- Medicare participating
At a glance
- Medical school
- University of Arkansas College of Medicine (2000)
- Years since graduation
- 26
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 446
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2000Medical school: University of Arkansas College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Otology & Neurotology Physician primary
KS license 04-31872 · MO license 2006015215
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Lukes Hospital of Kansas City Kansas City, MO
- Adventhealth Shawnee Mission Shawnee Mission, KS
- Golden Valley Memorial Hospital Clinton, MO
- Ascentist Hospital LLC Leawood, KS
Medical groups
- Ascentist Physicians Group LLC (119 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 446
- Services billed
- 1,240
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 362 | 288 |
| Removal of impacted ear wax | 328 | 231 |
| Established patient office or other outpatient visit, 20-29 minutes | 160 | 128 |
| New patient office or other outpatient visit, 45-59 minutes | 92 | 92 |
| Established patient office or other outpatient visit, 10-19 minutes | 56 | 35 |
| Complex removal of skin debris and drainage of mastoid cavity | 46 | 28 |
| Established patient office or other outpatient visit, 40-54 minutes | 36 | 33 |
| Incision of fluid canal of inner ear with infusion of drugs | 34 | 14 |
| Injection, dexamethasone sodium phosphate, 1 mg | 33 | 15 |
| Insertion of cochlear device | 31 | 30 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Cephalexin Other prescribers in Overland PArk, KS | 92 |
| Oxycodone Hcl Other prescribers in Overland PArk, KS | 86 |
| Ciprofloxacin Hcl Other prescribers in Overland PArk, KS | 32 |
| Triamterene-Hydrochlorothiazid (triamterene/hydrochlorothiazid) Other prescribers in Overland PArk, KS | 31 |
| Ofloxacin Other prescribers in Overland PArk, KS | 27 |
| Prednisone Other prescribers in Overland PArk, KS | 26 |
| Nortriptyline Hcl Other prescribers in Overland PArk, KS | 25 |
| Fluocinolone Acetonide Oil | 22 |
| Methylprednisolone Other prescribers in Overland PArk, KS | 13 |
| Alprazolam Other prescribers in Overland PArk, KS | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 4 payments worth $16,149 in total to this clinician.
| Cochlear Americas | $15,993 |
|---|---|
| Smith+nephew, Inc. | $108 |
| Genzyme Corporation | $30.62 |
| GlaxoSmithKline, LLC. | $16.90 |
| Travel and Lodging | $15,993 |
|---|---|
| Food and Beverage | $155 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Cochlear Americas Sep 25, 2025 | Travel and Lodging COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE; BAHA; OSIA OSI300 IMPLANT · Implantable hearing solution · travel to Sydney, Australia Company’s descriptionTravel associated with business interaction | $15,993 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $149,119 in research payments for these studies, mostly to the institutions running them.
- Perimodiolar Implant Performance in Adults with Low-Frequency Residual Hearing
Cochlear Americas
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.